除了低密度脂蛋白胆固醇，前蛋白转化酶枯草溶菌素9的新作用。 - Suppr

Suppr

超能文献

Beyond LDL cholesterol, a new role for PCSK9.

作者信息

Akram Omar N, Bernier Adeline, Petrides Francine, Wong Gida, Lambert Gilles

出版信息

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1279-81. doi: 10.1161/ATVBAHA.110.209007.

DOI:10.1161/ATVBAHA.110.209007

PMID:20554949

Abstract

摘要

相似文献

Beyond LDL cholesterol, a new role for PCSK9.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1279-81. doi: 10.1161/ATVBAHA.110.209007.

Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9 under physiological genetic control.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1333-9. doi: 10.1161/ATVBAHA.110.204040. Epub 2010 May 6.

PCSK9 and LDL cholesterol: unravelling the target to design the bullet.

Trends Biochem Sci. 2008 Sep;33(9):426-34. doi: 10.1016/j.tibs.2008.06.005. Epub 2008 Jul 30.

Protease variants, LDL, and coronary heart disease.

N Engl J Med. 2006 Mar 23;354(12):1310-2. doi: 10.1056/NEJMe068026.

Inhibition of PCSK9: is this the way forward for managing residual risk?

Curr Opin Lipidol. 2012 Oct;23(5):509-10. doi: 10.1097/MOL.0b013e328358246a.

What promise does PCSK9 hold?

J Am Coll Cardiol. 2005 May 17;45(10):1620-1. doi: 10.1016/j.jacc.2005.02.056.

Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia.

Curr Opin Lipidol. 2005 Apr;16(2):167-72. doi: 10.1097/01.mol.0000162321.31925.a3.

Inhibition of PCSK9 as a novel strategy for the treatment of hypercholesterolemia.

Drug News Perspect. 2008 Jul-Aug;21(6):323-30. doi: 10.1358/dnp.2008.21.6.1246795.

Targeting PCSK9 for the treatment of hypercholesterolemia.

Curr Opin Investig Drugs. 2009 Sep;10(9):938-46.

Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes.

Clin Chim Acta. 2010 Feb;411(3-4):229-33. doi: 10.1016/j.cca.2009.11.008. Epub 2009 Nov 13.

引用本文的文献

PCSK9 inhibitor in acute ischemic stroke patient receiving mechanical thrombectomy: early outcomes and safety.

Front Neurol. 2024 May 16;15:1375609. doi: 10.3389/fneur.2024.1375609. eCollection 2024.

The Link between miRNAs and PCKS9 in Atherosclerosis.

Curr Med Chem. 2024;31(42):6926-6956. doi: 10.2174/0109298673262124231102042914.

Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes.

Cardiovasc Diabetol. 2022 May 20;21(1):80. doi: 10.1186/s12933-022-01519-3.

Candidate Gene Analysis Reveals Strong Association of Variants With High Density Lipoprotein Cholesterol and Variants With Low Density Lipoprotein Cholesterol in Ghanaian Adults: An AWI-Gen Sub-Study.

Front Genet. 2020 Oct 30;11:456661. doi: 10.3389/fgene.2020.456661. eCollection 2020.

Modelling of atherosclerosis in genetically modified animals.

Am J Transl Res. 2019 Aug 15;11(8):4614-4633. eCollection 2019.

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.

Diseases. 2018 Mar 17;6(1):22. doi: 10.3390/diseases6010022.

PCSK9 as a therapeutic target for cardiovascular disease.

Exp Ther Med. 2017 Mar;13(3):810-814. doi: 10.3892/etm.2017.4055. Epub 2017 Jan 17.

Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts.

Hum Genet. 2017 Feb;136(2):165-178. doi: 10.1007/s00439-016-1738-7. Epub 2016 Nov 15.

Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats.

BMC Gastroenterol. 2015 Oct 30;15:151. doi: 10.1186/s12876-015-0382-3.

Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management.

Cardiol Ther. 2015 Jun;4(1):25-38. doi: 10.1007/s40119-015-0037-z. Epub 2015 Mar 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验